<DOC>
	<DOCNO>NCT00005504</DOCNO>
	<brief_summary>To investigate venous thromboembolism two carefully conduct prospective epidemiologic study African American white adult -- Atherosclerosis Risk Communities ( ARIC ) Study Cardiovascular Health Study ( CHS ) .</brief_summary>
	<brief_title>Epidemiology Venous Thrombosis Pulmonary Embolism</brief_title>
	<detailed_description>BACKGROUND : Venous thromboembolism , comprise deep venous thrombosis ( DVT ) pulmonary embolism ( PE ) , major contributor morbidity mortality United States . Nevertheless , comprehensive , prospective , population-based epidemiologic study simultaneously examine lifestyle , molecular , biochemical risk factor important disease . DESIGN NARRATIVE : Deep venous thrombosis pulmonary embolism case identify verified order estimate incident rate hospitalize venous thromboembolism combine ARIC CHS cohort . The association venous thromboembolism determine prospectively demographic lifestyle factor , plasma lipid , medical history , hemostatic component ( include fibrinogen , platelet count , factor VIIc VIIIc ) use exist ARIC CHS data . A nested case control study conduct use store pre-diagnosis blood DNA specimens determine prospective association venous thromboembolism follow : level procoagulant anticoagulant factor relate genetic variant ( include factor V Leiden ) , fibrinolytic factor ( e.g. , plasminogen activator inhibitor-1 ) relate genetic variant , marker thrombin activation , potentially important biochemical relate genetic factor ( e.g. , homocysteine ) . The study renew 2003 extend event follow-up four year conduct longitudinal analysis incidence potential risk factor fully explore diet , frailty , hormone replace therapy obesity interaction . It renew 2008 conduct genome wide association study . It renew 2013 .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>